FRANKLIN LAKES, N.J. (June 22, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Brooke Story has been named president of the Surgery business unit, effective July 3.
Story will be responsible for driving the global strategic, operational and commercial performance of the Surgery business unit and will report to Rick Byrd, executive vice president (EVP) and president of the Interventional segment. Story currently serves as president of the Integrated Diagnostic Solutions (IDS) business unit within the BD Life Sciences Segment.
“Brooke has spent more than two decades in this industry with proven leadership capabilities that help address unmet needs in health care,” said Byrd. “She led IDS with a relentless focus on the core business and transformative solutions, supporting growth along the diagnostic continuum from specimen management to molecular diagnostics and informatics to microbiology. As president of our fast-growing Surgery business, she will be uniquely positioned to expand our impact as we deliver innovative solutions and products to surgeons around the globe.”
Story joined BD in 2021, further advancing her extensive background within the medical technology industry. Prior to BD, she worked at Medtronic where she had most recently led its Pelvic Health and Gastric Therapies business to bring life-restoring solutions for pelvic floor disorders to patients. Joining BD Surgery enables her to return to her foundation in medical devices and technology and strongly aligns with her passion for driving better outcomes for patients. She holds a Master of Business Administration from the University of Michigan and a Bachelor of Science in Industrial Engineering from the University of Tennessee.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 77,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.
Contacts:
Media:
Troy Kirkpatrick
VP, Public Relations
858.617.2361
troy.kirkpatrick@bd.com
Investors:
Francesca DeMartino
SVP, Head of Investor Relations
201.847.5743
francesca.demartino@bd.com